Literature DB >> 20002172

Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.

Yoshimi Arima1, Hidemi Hayashi, Kanako Kamata, Takaaki M Goto, Mikako Sasaki, Akira Kuramochi, Hideyuki Saya.   

Abstract

Plexiform and/or dermal neurofibromas are nerve sheath tumors of the peripheral nervous system that are usually present in individuals with neurofibromatosis type 1 (NF1). Neurofibromas arise from Schwann cells with biallelic inactivation of NF1, the gene that encodes neurofibromin. This protein is responsible for regulation of the Ras-mediated pathway, which has been shown to play a crucial role in epithelial-to-mesenchymal transition (EMT). EMT is a biological process that occurs during embryogenesis and wound healing and is involved in pathological processes such as organ fibrosis and cancer metastasis. However, the relationship between neurofibromin and EMT has not been elucidated. We investigated whether the EMT-related signaling pathway was upregulated in NF1-associated neurofibromas and Schwann cells by assessing the expression levels of the EMT-related transcription factors Snail, Slug, Twist, ZEB1 and ZEB2. Immunohistochemical studies and quantitative reverse transcription polymerase chain reaction revealed an increase in the expression levels of EMT-related transcription factors in neurofibroma specimens and NF1-derived Schwann cells (sNF96.2). In addition, the silencing of NF1 by siRNA induced the expression of EMT-related transcription factors in normal human Schwann cells and in epithelial-like breast cancer cells. Our findings suggest that the loss of neurofibromin activated the EMT-related signaling pathway and that the excessive mesenchymal reaction may play a key role in the development of NF1-associated neurofibromas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20002172     DOI: 10.1111/j.1600-0625.2009.01017.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  16 in total

1.  Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Takahiro Kodama; Justin Y Newberg; Michiko Kodama; Roberto Rangel; Kosuke Yoshihara; Jean C Tien; Pamela H Parsons; Hao Wu; Milton J Finegold; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 2.  Molecular and clinical aspects of drug-induced gingival overgrowth.

Authors:  P C Trackman; A Kantarci
Journal:  J Dent Res       Date:  2015-02-13       Impact factor: 6.116

3.  Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.

Authors:  Matthew D Wood; Gerald F Reis; David E Reuss; Joanna J Phillips
Journal:  J Neuropathol Exp Neurol       Date:  2016-08-18       Impact factor: 3.685

4.  MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells.

Authors:  Pierpaolo Peruzzi; Agnieszka Bronisz; Michal O Nowicki; Yan Wang; Daisuke Ogawa; Richard Price; Ichiro Nakano; Chang-Hyuk Kwon; Josie Hayes; Sean E Lawler; Michael C Ostrowski; E Antonio Chiocca; Jakub Godlewski
Journal:  Neuro Oncol       Date:  2013-06-03       Impact factor: 12.300

5.  Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver.

Authors:  Marsha D Wallace; Adam D Pfefferle; Lishuang Shen; Adrian J McNairn; Ethan G Cerami; Barbara L Fallon; Vera D Rinaldi; Teresa L Southard; Charles M Perou; John C Schimenti
Journal:  Genetics       Date:  2012-07-30       Impact factor: 4.562

Review 6.  Neurofibromin and suppression of tumorigenesis: beyond the GAP.

Authors:  Juan Mo; Stefanie L Moye; Renee M McKay; Lu Q Le
Journal:  Oncogene       Date:  2022-01-23       Impact factor: 8.756

Review 7.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

8.  Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.

Authors:  Ritsuko Harigai; Shigeki Sakai; Hiroyuki Nobusue; Chikako Hirose; Oltea Sampetrean; Noriaki Minami; Yukie Hata; Takashi Kasama; Takanori Hirose; Toshiki Takenouchi; Kenjiro Kosaki; Kazuo Kishi; Hideyuki Saya; Yoshimi Arima
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

9.  Neurofibromatosis type-1 is a prognostic indicator in human gastric carcinoma.

Authors:  Debao Liu; Yueying Zhang; Yan Li; Kaixi Fan
Journal:  Oncotarget       Date:  2017-08-03

10.  Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.

Authors:  Matthew D Wood; Joydeep Mukherjee; Russell O Pieper
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.